ENTITY
Chugai Pharmaceutical

Chugai Pharmaceutical (4519 JP)

146
Analysis
Health Care • Japan
Chugai Pharmaceutical Company Ltd., manufactures and sells pharmaceuticals in the domestic and international markets through its subsidiaries. The Company develops drugs in the fields of cancer, infectious diseases, bone, blood, and circulatory systems. Chugai Pharmaceutical also conducts research studies on drugs with private and public medical research institutions.
more
•31 Jan 2020 07:05

🇯🇵 JAPAN • Results & Revisions Daily Roundup - 30th January ▲ 8316•6702•8604 ▼ 6770•9064•4661

30TH JANUARY ROUNDUP - Thre were 194 results and 64 forecasts or revisions announcements yesterday. Of the 85 larger-cap companies reporting...

Logo
323 Views
Share
bullish•Quantitative Analysis
•15 Dec 2019 13:59

🇯🇵 JAPAN • December Sector & Peer Group Relative Price Scores - From Defensives to Cylicals

• RELATIVE PRICE SCORE •RELATIVE PRICE SCORE OUTLIERS - The Relative Price Score (RPS) is a measure of price performance relative to TOPIX...

Logo
339 Views
Share
bullish•MSCI World Index
•11 Dec 2019 07:37

Global Equities Headed Up and to the Right: Technology, Health Care Leading

Our weight of the evidence approach leads us to believe the market remains in the early stages of a broad-based advance, meaning a buy-the-dip...

Logo
450 Views
Share
•01 Nov 2019 20:34

Developed Markets Strategy: Stick with Japan

Despite EAFE’s YTD outperformance relative to EM, EAFE and EM returns have generally been equal since August, shown by the stalemate in the EAFE...

Logo
444 Views
Share
•30 Sep 2019 07:47

Developed Markets Opportunities

Continue to favor EAFE over EM. As long as the U.S. dollar remains elevated, we believe  developed international (EAFE) will remain in a leadership...

Logo
462 Views
Share
x